Maria Luisa Barbaccia

Fonte dei dati: Archivio della Ricerca
  1. Atzori, M.g., Ceci, C., Ruffini, F., Trapani, M., Barbaccia, M.l., Tentori, L., et al. (2020). Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 24(1), 465-475 [10.1111/jcmm.14755]. Dettagli
  2. Lisi, L., Lacal, P., Barbaccia, M., & Graziani, G. (2020). Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2. BIOCHEMICAL PHARMACOLOGY, 180, 114169. Dettagli
  3. Franzese, O., Barbaccia, M.L., Bonmassar, E., & GRAZIANI, G. (2018). Beneficial and Detrimental Effects of Antiretroviral Therapy on HIV-Associated Immunosenescence. CHEMOTHERAPY, 63(2), 64-75 [10.1159/000487534]. Dettagli
  4. Franzese, O., Battaini, F., GRAZIANI, G., Tentori, L., Barbaccia, M.L., Aquino, A., et al. (2018). Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain?. PHARMACOLOGICAL RESEARCH, 131, 1-6 [10.1016/j.phrs.2018.03.005]. Dettagli
  5. Ceci, C., Barbaccia, M.L., & Pistritto, G. (2015). A not cytotoxic nickel concentration alters the expression of neuronal differentiation markers in NT2 cells. NEUROTOXICOLOGY, 47, 47-53 [10.1016/j.neuro.2015.01.001]. Dettagli
  6. Aquino, A., Barbaccia, M.L., Battaini, F., Bonmassar, E., Franzese, O., Graziani, G., et al. (2015). I FARMACI E LA FRAGILITA’. In I farmaci e le sfide di una medicina a misura di paziente. Universitalia. Dettagli
  7. Barbaccia, M.L., & Bonmassar, E. (2015). Innovazione farmacologica e pratica clinica. In M.L. Barbaccia, & M. Trabucchi (a cura di), I farmaci e le sfide di una medicina a misura di paziente (pp. 7-31). Roma : Universitalia. Dettagli
  8. Di Pietro, M.L., Cutrera, R., Teleman, A.A., & Barbaccia, M.L. (2015). Placebo-controlled trials in pediatrics and the child's best interest. THE ITALIAN JOURNAL OF PEDIATRICS, 41(1), 11 [10.1186/s13052-015-0118-6]. Dettagli
  9. Aquino, A, Barbaccia, M.L., Battaini, F., Bonmassar, E., Franzese, O., et al. (2014). INVECCHIAMENTO, IMMUNITÀ E FARMACI. In APPUNTI DI FARMACOLOGIA DEI SISTEMI. Universitalia. Dettagli
  10. Barbaccia, M.L. (2014). Approcci metodologici per una farmacoterapia moderna: Evidence Based Medicine e Systems Medicine. In Maria Luisa Barbaccia e Marco Trabucchi (a cura di), Appunti di farmacologia dei sistemi (pp. 1-35). Roma : Universitalia. Dettagli
  11. Pistritto, G., Papaleo, V., Sanchez, P., Ceci, C., & Barbaccia, M.L. (2012). Divergent modulation of neuronal differentiation by caspase-2 and -9. PLOS ONE, e36002 [10.1371/journal.pone.0036002.]. Dettagli
  12. Barbaccia, M.L. (2011). Much excitement about antidepressants, DBI and c-FOS. PHARMACOLOGICAL RESEARCH, 64, 333-335 [10.1016/j.phrs.2011.05.018]. Dettagli
  13. Bortolato, M., Devoto, P., Roncada, P., Frau, R., Flore, G., Saba, P., et al. (2011). Isolation rearing-induced reduction of brain 5α-reductase expression: relevance to dopaminergic impairments. NEUROPHARMACOLOGY, 60(7-8), 1301-1308 [10.1016/j.neuropharm.2011.01.013]. Dettagli
  14. Pistritto, G., Papacleovoulou, G., Ragone, G., Di Cesare, S., Papaleo, V., Mason, J.I., et al. (2009). Differentiation-dependent progesterone synthesis and metabolism in NT2-N human neurons. EXPERIMENTAL NEUROLOGY, 217(2), 302-311. Dettagli
  15. Pistritto, G., Papacleovoulou, G., Ragone, G., Di Cesare, S., Papaleo, V., Mason, J.I., et al. (2009). Differentiation-dependent progesterone synthesis and metabolism in NT2-N human neurons. EXPERIMENTAL NEUROLOGY, 217(2), 302-311. Dettagli
  16. Barbaccia, M.L., Scaccianoce, S., Del Bianco, P., Campolongo, P., Trezza, V., Tattoli, M., et al. (2007). Cognitive impairment and increased brain neurosteroids in adult rats perinatally exposed to low millimolar blood alcohol concentrations. PSYCHONEUROENDOCRINOLOGY, 32, 931-942. Dettagli
  17. Barbaccia, M.L., Carai, M., Colombo, G., Lobina, C., Purdy, R.H., & Gessa, G.L. (2005). Endogenous gamma-aminobutyric acid (GABA)(A) receptor active neurosteroids and the sedative/hypnotic action of gamma-hydroxybutyric acid (GHB): A study in GHB-S (sensitive) and GHB-R (resistant) rat lines. NEUROPHARMACOLOGY, 49(1), 48-58. Dettagli
  18. Barbaccia M.L. (2004). Neurosteroidogenesis: Relevance to neurosteroid actions in brain and modulation by psychotropic drugs. CRITICAL REVIEWS IN NEUROBIOLOGY, 16(1/2), 67-74 [10.1615/CritRevNeurobiol.v16.i12.70]. Dettagli
  19. Albo, F., Barbaccia, M.L., Cavazza, A., Marini, M., & Roda, L.G. (2003). Dehydroepiandrosterone metabolism in human plasma. HORMONE AND METABOLIC RESEARCH, 35(2), 104-108. Dettagli
  20. Barbaccia M.L., C.G. (2002). GABA(B) receptor-mediated increase of neurosteroids by gamma-hydroxybutyric acid. NEUROPHARMACOLOGY, 42(6), 782-791 [10.1016/S0028-3908(02)00026-6]. Dettagli
  21. Maccarrone M., V.O. (2002). Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. EUROPEAN JOURNAL OF NEUROSCIENCE, 15(7), 1178-1186 [10.1046/j.1460-9568.2002.01957.x]. Dettagli
  22. Barbaccia M.L., A.D. (2001). Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat. NEUROPSYCHOPHARMACOLOGY, 25(4), 489-497. Dettagli
  23. Barbaccia, M.L., Serra, M., Purdy, R.H., & Biggio, G. (2001). Stress and neuroactive steroids. In G. Biggio, & R.H. Purdy (a cura di), Neurosteroids and brain function (pp. 243-272). Elsevier. Dettagli
  24. Barbaccia, M.L., Lello, S., Sidiropoulou, T., Cocco, T., Sorge, R.P., Cocchiarale, A., et al. (2000). Plasma 5alpha-androstane-3alpha,17betadiol, an endogenous steroid that positively modulates GABA(A) receptor function, and anxiety: a study in menopausal women. PSYCHONEUROENDOCRINOLOGY, 25(7), 659-675. Dettagli
  25. Ghezzi, P., Di Santo, E., Sacco, S., Foddi, C., Barbaccia, M.L., & Mennini, T. (2000). Neurosteroid levels are increased in vivo after LPS treatment and negatively regulate LPS-induced TNF production. EUROPEAN CYTOKINE NETWORK, 11(3), 464-469. Dettagli
  26. Barbaccia, M.L., Affricano, D., Trabucchi, M., Purdy, R.H., Colombo, G., Agabio, R., et al. (1999). Ethanol markedly increases "GABAergic" neurosteroids in alcohol-preferring rats. EUROPEAN JOURNAL OF PHARMACOLOGY, 384(2-3), R1-R2. Dettagli
  27. Concas A., F.P. (1999). Physiological modulation of GABA(A) receptor plasticity by progesterone metabolites. In European Journal of Pharmacology (pp.225-235). AMSTERDAM : ELSEVIER SCIENCE BV [10.1016/S0014-2999(99)00232-0]. Dettagli
  28. Concas, A., Mostallino, M.C., Porcu, P., Follesa, P., Barbaccia, M.L., Trabucchi, M., et al. (1998). Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 95(22), 13284-13289. Dettagli
  29. Roscetti, G., Del Carmine, R., Trabucchi, M., Massotti, M., Purdy, R.H., & Barbaccia, M.L. (1998). Modulation of neurosteroid synthesis/accumulation by L-ascorbic acid in rat brain tissue: inhibition by selected serotonin antagonists. JOURNAL OF NEUROCHEMISTRY, 71(3), 1108-1117. Dettagli
  30. Barbaccia M.L., C.A. (1998). Stress and neurosteroids in adult and aged rats. In Experimental Gerontology (pp.697-712). OXFORD : PERGAMON-ELSEVIER SCIENCE LTD. Dettagli
  31. Barbaccia, M.L., Roscetti, G., Trabucchi, M., Purdy, R.H., Mostallino, M.C., Concas, A., et al. (1997). The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. BRITISH JOURNAL OF PHARMACOLOGY, 120(8), 1582-1588. Dettagli
  32. Concas, A., Mostallino, M.C., Perra, C., Lener, R., Roscetti, G., Barbaccia, M.L., et al. (1996). Functional correlation between allopregnanolone and [35S]-TBPS binding in the brain of rats exposed to isoniazid, pentylenetetrazol or stress. BRITISH JOURNAL OF PHARMACOLOGY, 118(4), 839-846. Dettagli
  33. Barbaccia, M.L., Roscetti, G., Bolacchi, F., Concas, A., Mostallino, M.C., Purdy, R.H., et al. (1996). Stress-induced increase in brain neuroactive steroids: antagonism by abecarnil. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 54(1), 205-210. Dettagli
  34. Barbaccia, M.L., Roscetti, G., Trabucchi, M., Mostallino, M.C., Concas, A., Purdy, R.H., et al. (1996). Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress. NEUROENDOCRINOLOGY, 63(2), 166-172. Dettagli
  35. Barbaccia, M.L., Roscetti, G., Trabucchi, M., Purdy, R.H., Mostallino, M.C., Perra, C., et al. (1996). Isoniazid-induced inhibition of GABAergic transmission enhances neurosteroid content in the rat brain. NEUROPHARMACOLOGY, 35(9-10), 1299-1305. Dettagli
  36. Roscetti, G., Ambrosio, C., Trabucchi, M., Massotti, M., & Barbaccia, M.L. (1994). Modulatory mechanisms of cyclic AMP-stimulated steroid content in rat brain cortex. EUROPEAN JOURNAL OF PHARMACOLOGY, 269(1), 17-24. Dettagli
  37. Barbaccia, M.L., Roscetti, G., Trabucchi, M., Cuccheddu, T., Concas, A., & Biggio, G. (1994). Neurosteroids in the brain of handling-habituated and naive rats: effect of CO2 inhalation. EUROPEAN JOURNAL OF PHARMACOLOGY, 261(3), 317-320. Dettagli
  38. Barbaccia, M.L., Roscetti, G., Trabucchi, M., Ambrosio, C., & Massotti, M. (1992). Cyclic AMP-dependent increase of steroidogenesis in brain cortical minces. EUROPEAN JOURNAL OF PHARMACOLOGY, 219(3), 485-486. Dettagli
  39. Roy, A., DeJong, J., Adinoff, B., Barbaccia, M., Costa, E., Guidotti, A., et al. (1990). CSF diazepam-binding inhibitor in alcoholics and normal controls. PSYCHIATRY RESEARCH, 31(3), 261-266. Dettagli
  40. Barbaccia, M.L., Berkovich, A., Guarneri, P., & Slobodyansky, E. (1990). DBI (diazepam binding inhibitor): the precursor of a family of endogenous modulators of GABAA receptor function. History, perspectives, and clinical implications. NEUROCHEMICAL RESEARCH, 15(2), 161-168. Dettagli
  41. Roy, A., Pickar, D., Gold, P., Barbaccia, M., Guidotti, A., Costa, E., et al. (1989). Diazepam-binding inhibitor and corticotropin-releasing hormone in cerebrospinal fluid. ACTA PSYCHIATRICA SCANDINAVICA, 80(3), 287-291. Dettagli
  42. Rothstein, J.D., McKhann, G., Guarneri, P., Barbaccia, M.L., Guidotti, A., & Costa, E. (1989). Cerebrospinal fluid content of diazepam binding inhibitor in chronic hepatic encephalopathy. ANNALS OF NEUROLOGY, 26(1), 57-62. Dettagli
  43. Szekely, A.M., Barbaccia, M.L., Alho, H., & Costa, E. (1989). In primary cultures of cerebellar granule cells the activation of N-methyl-D-aspartate-sensitive glutamate receptors induces c-fos mRNA expression. MOLECULAR PHARMACOLOGY, 35(4), 401-408. Dettagli
  44. Roy, A., Adinoff, B., Roehrich, L., Lamparski, D., Custer, R., Lorenz, V., et al. (1988). Pathological gambling. A psychobiological study. ARCHIVES OF GENERAL PSYCHIATRY, 45(4), 369-373. Dettagli
  45. Barbaccia, M.L., Costa, E., & Guidotti, A. (1988). Endogenous ligands for high-affinity recognition sites of psychotropic drugs. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 28, 451-476. Dettagli
  46. Szekely, A.M., Barbaccia, M.L., & Costa, E. (1987). Activation of specific glutamate receptor subtypes increases C-fos proto-oncogene expression in primary cultures of neonatal rat cerebellar granule cells. NEUROPHARMACOLOGY, 26(12), 1779-1782. Dettagli
  47. Szekely, A.M., Barbaccia, M.L., & Costa, E. (1987). Effect of a protracted antidepressant treatment on signal transduction and [3H](-)-baclofen binding at GABAB receptors. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 243(1), 155-159. Dettagli
  48. Barbaccia, M.L., Costa, E., Ferrero, P., Guidotti, A., Roy, A., Sunderland, T., et al. (1986). Diazepam-binding inhibitor. A brain neuropeptide present in human spinal fluid: studies in depression, schizophrenia, and Alzheimer's disease. ARCHIVES OF GENERAL PSYCHIATRY, 43(12), 1143-1147. Dettagli
  49. Barbaccia, M.L., Melloni, P., Pozzi, O., & Costa, E. (1986). [3H]imipramine displacement and 5HT uptake inhibition by tryptoline derivatives: in rat brain 5-methoxytryptoline is not the autacoid for [3H]imipramine recognition sites. EUROPEAN JOURNAL OF PHARMACOLOGY, 123(1), 45-52. Dettagli
  50. Barbaccia, M.L., Ravizza, L., & Costa, E. (1986). Maprotiline: an antidepressant with an unusual pharmacological profile. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 236(2), 307-312. Dettagli
  51. Nicoletti, F., Barbaccia, M.L., Iadarola, M.J., Pozzi, O., & Laird, H.E. (1986). Abnormality of alpha 1-adrenergic receptors in the frontal cortex of epileptic rats. JOURNAL OF NEUROCHEMISTRY, 46(1), 270-273. Dettagli
  52. Gandolfi, O., Barbaccia, M.L., & Costa, E. (1985). Different effects of serotonin antagonists on 3H-mianserin and 3H-ketanserin recognition sites. LIFE SCIENCES, 36(8), 713-721. Dettagli
  53. Ravizza, L., Nicoletti, F., Pozzi, O., & Barbaccia, M.L. (1985). Repeated daily treatments with estradiol benzoate increase the [3H]imipramine binding in male rat frontal cortex. EUROPEAN JOURNAL OF PHARMACOLOGY, 107(3), 395-396. Dettagli
  54. Barbaccia, M.L., Karoum, F., & Costa, E. (1985). Characterization of the endocoid for imipramine recognition sites. PROGRESS IN CLINICAL AND BIOLOGICAL RESEARCH, 192, 431-433. Dettagli
  55. Gandolfi, O., Barbaccia, M.L., & Costa, E. (1984). Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 229(3), 782-786. Dettagli
  56. Gandolfi, O., Barbaccia, M.L., & Costa, E. (1984). The (-)-deprenyl actions on beta-adrenergic receptors require the integrity of brain serotonergic axon terminals. EUROPEAN JOURNAL OF PHARMACOLOGY, 100(2), 233-237. Dettagli
  57. Barbaccia, M.L., & Costa, E. (1984). Autacoids for drug receptors: a new approach in drug development. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 430, 103-114. Dettagli
  58. Costa, E., Chuang, D.M., Barbaccia, M.L., & Gandolfi, O. (1983). Molecular mechanisms in the action of imipramine. EXPERIENTIA, 39(8), 855-858. Dettagli
  59. Barbaccia, M.L., Gandolfi, O., Chuang, D.M., & Costa, E. (1983). Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 80(16), 5134-5138. Dettagli
  60. Gandolfi, O., Barbaccia, M.L., Chuang, D.M., & Costa, E. (1983). Daily bupropion injections for 3 weeks attenuate the NE stimulation of adenylate cyclase and the number of beta-adrenergic recognition sites in rat frontal cortex. NEUROPHARMACOLOGY, 22(7), 927-929. Dettagli
  61. Barbaccia, M.L., Brunello, N., Chuang, D.M., & Costa, E. (1983). Serotonin-elicited amplification of adenylate cyclase activity in hippocampal membranes from adult rat. JOURNAL OF NEUROCHEMISTRY, 40(6), 1671-1679. Dettagli
  62. Zsilla, G., Barbaccia, M.L., Gandolfi, O., Knoll, J., & Costa, E. (1983). (-)-Deprenyl a selective MAO "B' inhibitor, increases [3H]imipramine binding and decreases beta-adrenergic receptor function. EUROPEAN JOURNAL OF PHARMACOLOGY, 89(1-2), 111-117. Dettagli
  63. Barbaccia, M.L., Brunello, N., Chuang, D.M., & Costa, E. (1983). On the mode of action of imipramine: relationship between serotonergic axon terminal function and down-regulation of beta-adrenergic receptors. NEUROPHARMACOLOGY, 22(3 Spec No), 373-383. Dettagli
  64. Barbaccia, M.L., Gandolfi, O., Chuang, D.M., & Costa, E. (1983). Differences in the regulatory adaptation of the 5HT recognition sites labelled by 3H-mianserin or 3H-ketanserin. NEUROPHARMACOLOGY, 22(1), 123-126. Dettagli
  65. Brunello, N., Barbaccia, M.L., Chuang, D.M., & Costa, E. (1982). Down-regulation of beta-adrenergic receptors following repeated injections of desmethylimipramine: permissive role of serotonergic axons. NEUROPHARMACOLOGY, 21(11), 1145-1149. Dettagli
  66. Barbaccia, M.L., Bosio, A., Lucchi, L., Spano, P.F., & Trabucchi, M. (1982). Neuronal mechanisms regulating ethanol effects on the dopaminergic system. LIFE SCIENCES, 30(25), 2163-2170. Dettagli
  67. Barbaccia, M.L., Lucchi, L., Kobayashi, H., Spano, P.F., Govoni, S., & Trabucchi, M. (1982). Modulation of dopamine turnover in rat retina by opiates: effects of different pharmacological treatments. PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 14(6), 541-550. Dettagli
  68. Barbaccia, M.L., Bosio, A., Spano, P.F., & Trabucchi, M. (1982). Ethanol metabolism and striatal dopamine turnover. JOURNAL OF NEURAL TRANSMISSION, 53(2-3), 169-177. Dettagli
  69. Barbaccia, M.L., Chuang, D.M., & Costa, E. (1982). Is insulin a neuromodulator?. ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY, 33, 511-518. Dettagli
  70. Barbaccia, M.L., Reggiani, A., Spano, P.F., & Trabucchi, M. (1981). Ethanol-induced changes of dopaminergic function in three strains of mice characterized by a different population of opiate receptors. PSYCHOPHARMACOLOGY, 74(3), 260-262. Dettagli
  71. Reggiani, A., Barbaccia, M.L., Spano, P.F., & Trabucchi, M. (1980). Dopamine metabolism and receptor function after acute and chronic ethanol. JOURNAL OF NEUROCHEMISTRY, 35(1), 34-37. Dettagli
  72. Barbaccia, M.L., & Trabucchi, M. (1980). Tardive dyskinesia: a biological appraoch. PROGRESS IN CLINICAL AND BIOLOGICAL RESEARCH, 39, 181-193. Dettagli
  73. Barbaccia, M.L., Reggiani, A., Spano, P.F., & Trabucchi, M. (1980). Ethanol effects on dopaminergic function: modulation by the endogenous opioid system. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 13 Suppl 1, 303-306. Dettagli
  74. Reggiani, A., Barbaccia, M.L., Spano, P.F., & Trabucchi, M. (1980). Acute and chronic ethanol administration on specific 3H-GABA binding in different rat brain areas. PSYCHOPHARMACOLOGY, 67(3), 261-264. Dettagli
  75. Reggiani, A., Barbaccia, M.L., Spano, P.F., & Trabucchi, M. (1980). Role of dopaminergic-enkephalinergic interactions in the neurochemical effects of ethanol. SUBSTANCE AND ALCOHOL ACTIONS/MISUSE, 1(2), 151-158. Dettagli